This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects and complete follow-up assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
Multiple locations, including Vienna
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.
This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Taking part may give some people access to Six un-medicated and six medicated subjects diagnosed with schizophrenia will be compared to six age-matched healthy volunteers, but direct benefit is not guaranteed.
This study is looking at whether [A] Cognitive Behavioural Case Management [B] Treatment-as-usual can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in [A] Cognitive Behavioural Case Management [B] Treatment-as-usual and complete follow-up assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
This study is looking at whether a digital support tool can help people with psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Randomised trial with three groups: 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Randomised trial with three groups: 1 and complete follow-up assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.